Neil Desai
Presidente en AADI BIOSCIENCE, INC. .
Fortuna: 3 M $ al 30/04/2024
Origen de la red de primer grado Neil Desai.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
79
| Subsidiary | Biotechnology | 79 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL
32
| Extinct | Pharmaceuticals: Major | 32 |
| Public Company | Biotechnology | 20 | |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.
12
| Extinct | Pharmaceuticals: Major | 12 |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA.
10
| Subsidiary | Biotechnology | 10 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Neil Desai a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Sales & Marketing | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Founder Director/Board Member President Chief Administrative Officer Public Communications Contact General Counsel Chief Operating Officer | |
Stalar 3, Inc.
 Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Financial Conglomerates | President Director of Finance/CFO | |
Fresenius Kabi Pharmaceuticals Holding LLC
 Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member President General Counsel Chief Operating Officer | |
| RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| NANTHEALTH, INC. | Packaged Software | Founder Director/Board Member Director/Board Member | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
| Brown University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
Abraxis Pharmaceutical Products
 Abraxis Pharmaceutical Products Medical SpecialtiesHealth Technology Abraxis Pharmaceutical Products provides injectible pharmaceutical products. It offers anti-infective, critical care, oncology and anesthetic/analgesic products. The company is located in Schaumburg, IL. | Medical Specialties | President President Chief Operating Officer | |
Kearny Venture Partners
 Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chairman | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
NantWorks LLC
 NantWorks LLC Information Technology ServicesTechnology Services NantWorks LLC develops technology based semiconductor and advanced networks for healthcare improvements. Its solution is for life threatening diseases such as cancer, infectious diseases and Alzheimer’s. The company was founded by Patrick Soon-Shiong in September 2011 and is headquartered in Culver City, CA. | Information Technology Services | Chief Executive Officer General Counsel Corporate Officer/Principal Human Resources Officer | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| UROGEN PHARMA LTD. | Biotechnology | Consultant / Advisor Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Treasurer | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Consultant / Advisor Chief Tech/Sci/R&D Officer | |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer |
Estadísticas
Internacional
| Estados Unidos | 47 |
| Suiza | 3 |
| Suecia | 2 |
| Francia | 2 |
Sectorial
| Health Technology | 31 |
| Consumer Services | 12 |
| Finance | 5 |
| Commercial Services | 3 |
| Technology Services | 3 |
Operativa
| Director/Board Member | 490 |
| Corporate Officer/Principal | 275 |
| Independent Dir/Board Member | 156 |
| Chairman | 133 |
| Undergraduate Degree | 78 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Patrick Soon-Shiong | 52 |
| Jerome Zeldis | 38 |
| Perry Karsen | 38 |
| Thomas Daniel | 35 |
| Rodman L. Drake | 33 |
| Michael Bonney | 32 |
| Sol Barer | 32 |
| Lonnie Moulder | 31 |
| Michael Friedman | 30 |
| Richard Maroun | 27 |
| Richard W. Barker | 26 |
| Jean Bizzari | 24 |
| William Rastetter | 24 |
| Walter L. Robb | 23 |
| Caley Castelein | 23 |
- Bolsa de valores
- Insiders
- Neil Desai
- Conexiones Empresas